Liquid phase peptide synthesis of KL-4 pulmonary surfactant

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8217142
APP PUB NO 20090259021A1
SERIAL NO

12241171

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to improved liquid phase processes for the preparation of the 21 residue protein component, (Lys-Leu4)4-Lys, of the pulmonary surfactant KL-4. These process are amenable to large scale synthesis and one process employs a method of saponifying an ester which reduces the inherent racemization of the α-carbon.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ORTHO PHARMACEUTICAL CORPORATIONRARITAN NEW JERSEY 08869-0602

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Abdel-Magid, Ahmed F Lansdale, US 25 113
Eggmann, Urs Fluringen, CH 4 12
Maryanoff, Cynthia Anne New Hope, US 5 17
Thaler, Adrian Stetten, CH 5 15
Villani, Frank J Perkasie, US 38 549

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation